| 【Company Research】China Life (2628 HK) – Focus on agency upgrade |
| 【Fixed Income Research】KAISAG - Upside surprises |
| 【Fixed Income Research】EHouse - Profit Warning |
| 【Fixed Income Research】GZRFPR - More remedies needed |
| 【Company Research】Jiumaojiu (9922 HK) – Slightly more cautious after a bumpy Jul-Aug |
| 【Fixed Income Research】ZHLGHD - 1H21 Result in line with expectation |
| 【Company Research】Xiaomi (1810 HK) – 2Q21 beat on strong ads and margin; Maintain BUY |
| 【Company Research】AK Medical (1789 HK) – Results of volume-based procurement to come out in mid-September |
| 【Company Research】Ascentage Pharma Group (6855 HK) – Breakthrough in collaboration deals |
| 【Company Research】Kuaishou (1024 HK) – Cautious on 2H21E momentum |